246 related articles for article (PubMed ID: 6083507)
1. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
Custro N; De Francisci MC; Patanella I; Scafidi V; Indovina I
Minerva Med; 1984 Nov; 75(42):2527-32. PubMed ID: 6083507
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
[TBL] [Abstract][Full Text] [Related]
3. Half-life time or clearance of indocyanine green in patients with liver disease.
Gilmore IT; Marigold JH; Thompson RP
Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
[TBL] [Abstract][Full Text] [Related]
4. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
[TBL] [Abstract][Full Text] [Related]
5. [Cholescintigraphy and hepatic clearance of 99mTc-p-butyl HIDA in Gilbert's syndrome].
Custro N; De Francisci MC; Patanella I
Minerva Med; 1984 Nov; 75(42):2521-5. PubMed ID: 6514210
[TBL] [Abstract][Full Text] [Related]
6. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolite/caffeine ratios as a test for liver function.
Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of famotidine after intravenous administration in liver disease.
Ohnishi K
Am J Gastroenterol; 1991 Jan; 86(1):41-5. PubMed ID: 1986553
[TBL] [Abstract][Full Text] [Related]
9. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical investigation of the hepatobiliary agents: 99mTc-HIDA and 99mTc-p-butyl-IDA.
Agha NH; Al-Hilli AM; Dahir ND; Al-Hissoni MS; Jasim MN; Miran KM; Shubber AH
Nuklearmedizin; 1986 Oct; 25(5):181-7. PubMed ID: 3797257
[TBL] [Abstract][Full Text] [Related]
11. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
[TBL] [Abstract][Full Text] [Related]
12. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
Haustein KO; Schenker E
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
[TBL] [Abstract][Full Text] [Related]
13. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis.
Koeda N; Iwai M; Kato A; Suzuki K
Aliment Pharmacol Ther; 2005 Apr; 21(7):851-9. PubMed ID: 15801920
[TBL] [Abstract][Full Text] [Related]
14. [Plasma clearance of cholic acid in patients with chronic diseases of the liver].
Medrzejewski W; Habior A; Samociuk-Medrzejewska B; Cwikła M
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):335-7. PubMed ID: 2235721
[TBL] [Abstract][Full Text] [Related]
15. Does a long pre-operative hospital stay before hepatectomy improve liver dysfunction in HCC patients with chronic liver disease?
Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):472-6. PubMed ID: 9164521
[TBL] [Abstract][Full Text] [Related]
16. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
[TBL] [Abstract][Full Text] [Related]
17. [Metabolism of hexobarbital in patients with acute hepatitis and cirrhosis (author's transl)].
Richter E; Gallenkamp H; Keller B; Brachtel D; Zilly W; Breimer DD
Z Gastroenterol; 1977 Jun; 15(6):381-8. PubMed ID: 888488
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of cirrhosis and hepatitis by quantitative hepatic and other reticuloendothelial clearance rates.
DeNardo SJ; Bell GB; DeNardo GL; Carretta RF; Scheibe PO; Imperato TJ; Jackson PE
J Nucl Med; 1976 Jun; 17(6):449-59. PubMed ID: 1262962
[TBL] [Abstract][Full Text] [Related]
19. The effect of liver disease on urine caffeine metabolite ratios.
Denaro CP; Wilson M; Jacob P; Benowitz NL
Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
[TBL] [Abstract][Full Text] [Related]
20. The expression of bcl-2 in chronic liver diseases.
Mutluay R; Ozenirler S; Poyraz A
Saudi Med J; 2005 Aug; 26(8):1245-9. PubMed ID: 16127523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
